[Federal Register Volume 85, Number 76 (Monday, April 20, 2020)]
[Notices]
[Page 21891]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08271]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-625]


Importer of Controlled Substances Application: AMRI Rensselaer, 
Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturer of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before May 20, 2020. 
Such persons may also file a written request for a hearing on the 
application on or before May 20, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on March 9, 2020, AMRI Rensselaer, Inc., 33 Riverside 
Avenue, Rensselaer, New York 12144, applied to be registered as an 
importer of the following basic class(es) of a controlled substance:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Poppy Straw Concentrate.................    9670  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substance to 
manufacture a bulk controlled substance for distribution to its 
customers.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-08271 Filed 4-17-20; 8:45 am]
BILLING CODE 4410-09-P